ALFA FinderNSE filing, NSE: TORNTPHARM. Summary written from the filing by ALFA Finder's alert engine.
Torrent Pharmaceuticals Ltd: key numbers
- Share price
- ₹4,750.00
- Market cap
- ₹1,80,675 Cr
- Revenue (annual)
- ₹13,980 Cr
- Net profit (annual)
- ₹2,163 Cr
- P/E (TTM)
- 85.1×Sector 43.0×
- Promoter holding
- 60.78%-7.53% QoQ
- FII holding
- 17.22%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Torrent Pharmaceuticals Ltd
All →Torrent Pharmaceuticals Legal & Regulatory
Torrent Pharma received a ₹3.12 Crore GST penalty order for pre-acquisition JB Chemicals periods. The company will appeal and expects no material impact.
- Value
- ₹3.12 Cr
Torrent Pharmaceuticals Other Announcement
Torrent Pharmaceuticals disclosed that its RTA, KFin Technologies, is moving its corporate office effective December 1, 2026. Investors should update their records with the new address.
Torrent Pharmaceuticals Earnings Call Transcript: Key Takeaways
Revenue grew 51% following the JB Chemicals merger, but underlying business shows integration headwinds.
- Call
- Guides 10% growth
Torrent Pharmaceuticals Debt & Borrowing
Torrent Pharmaceuticals filed its security cover certificate as on 30-Sep-26 for listed NCDs, showing 141% market-value cover. Secured debt covered by the certificate stands at Rs 11,578.42 Crore.
Torrent Pharmaceuticals Q2 FY27 Results: Net Profit ₹534 Cr, Down 9.6% YoY
Torrent Pharmaceuticals Ltd reported revenue from operations of ₹4,979 Cr (+50.8% YoY) and net profit of ₹534 Cr (-9.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹534 Cr · -9.6% YoY
Torrent Pharmaceuticals Management Change
Torrent Pharmaceuticals' Executive Director, Amal Kelshikar, has resigned from his position effective October 16, 2026.
Other annual general meeting announcements
All →Meesho Annual General Meeting
Meesho seeks postal ballot approval, with voting closing 08-Dec-2026, to appoint Sudhir Sitapati as Independent Director. The resolution also covers ₹1 Crore annual remuneration.
Indrayani Biotech Annual General Meeting
Indrayani Biotech's 34th AGM is set for 30 November 2026, with book closure from 24 to 30 November. Remote e-voting runs 27 to 29 November 2026.
Kirloskar Ferrous Industries Annual General Meeting
Kirloskar Ferrous shareholders approved Ajay Shriram Patil's appointment as Director and Joint Managing Director via postal ballot. Both ordinary resolutions passed with over 98% votes in favour.
Gland Pharma Annual General Meeting
Gland Pharma's shareholders approved the appointment of Xingli Wang as Non-Executive Non-Independent Director via postal ballot. The ordinary resolution passed with 97.07% of votes in favour.
HDFC Bank Annual General Meeting
HDFC Bank's postal ballot passed the appointment of Anup Bagchi as Managing Director and CEO. Approval was deemed on 6 November 2026 with 98.646% votes in favour.
Britannia Industries Annual General Meeting
Britannia shareholders passed the special resolution appointing Sonny Iqbal as Non-Executive Independent Director via postal ballot. Approval was 99.7187% in favour of votes polled.